MedPath

Application of 2D and 3D Laparoscopy in Laparoscopic Pancreaticoduodenectomy: a Prospective Randomized Clinical Trial

Not Applicable
Conditions
Pancreatoduodenectomy
Interventions
Procedure: 2D Laparoscopic pancreatoduodenectomy
Procedure: 3D Laparoscopic pancreatoduodenectomy
Registration Number
NCT03754595
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

Pancreatic cancer is extremely malignant, with a low sensibility to chemotherapy and radiotherapy, and a poor prognosis. Surgical treatment is very important for pancreatic cancer. Laparoscopic pancreatoduodenectomy is a standard radical procedure we are going to compare and discuss the advantages of 2D and 3D Laparoscopic pancreatoduodenectomy in our RCT study.

Detailed Description

This study is to compare the efficiency and safety between 2D laparoscopic pancreatoduodenectomy and 2D laparoscopic pancreaticoduodenectomy for pancreatic cancer. We design a prospective randomized study. Patients with malignant pancreatic tumor who underwent pancreatoduodenectomy are recruited to the study. After obtaining informed consent, eligible patients are randomly allocated to 2D laparoscopic or 3D laparoscopic group before the operation day . The outcomes evaluated were hospital stay, and blood loss, radicality of surgery, duration of operation and complication rate.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria

Age: >18yr, <75yr Patients with pancreatic cancer or non-pancreatic cancers (biliary duct cancer or ampullary cancer) who underwent pancreatoduodenectomy Preoperative imaging assessment is resectable or borderline resectable -

Exclusion Criteria
  • Benign tumors of the head of pancreas Enhanced CT diagnosis revealed that the excess of SMV was more than 180 degrees, or distant metastasis.

conversion to laparotomy because of intraoperative difficulty

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2D Laparoscopic pancreatoduodenectomy2D Laparoscopic pancreatoduodenectomyPatients with pancreatic cancer treated by 2D Laparoscopic pancreatoduodenectomy
3D Laparoscopic pancreatoduodenectomy3D Laparoscopic pancreatoduodenectomyPatients with pancreatic cancer treated by 3D Laparoscopic pancreatoduodenectomy
Primary Outcome Measures
NameTimeMethod
Overall survival60 month

overall survival duration after surgical treatment

Secondary Outcome Measures
NameTimeMethod
Overall complicationsUp to postoperative 30 days

The proportion of all complications after operation accounted for the total number of patients

© Copyright 2025. All Rights Reserved by MedPath